A perfused iPSC-derived proximal tubule model for predicting drug-induced kidney injury

Michelle Lechtenberg1, Coraline Chéneau2, Kevin Riquin2

  • 1TissUse GmbH, Berlin, Germany.

Insights

A new kidney proximal tubule model using induced pluripotent stem cells (iPSCs) accurately predicts drug-induced kidney injury. This perfused model helps detect nephrotoxicity early, aiding drug development and prevention strategies.

Area of Science:

  • Nephrology
  • Toxicology
  • Stem Cell Biology

Background:

  • Kidneys are susceptible to drug and metabolite toxicity, particularly the proximal tubule (PT).
  • Early detection of drug-induced nephrotoxicity requires relevant in vitro models.
  • Current models may not fully replicate in vivo conditions for accurate toxicity prediction.

Purpose of the Study:

  • To develop and validate a robust, versatile in vitro model of the human proximal tubule using induced pluripotent stem cells (iPSCs).
  • To assess the model's capability in predicting drug-induced proximal tubule injury.
  • To investigate the impact of perfusion on xenobiotic response and metallothionein upregulation.

Main Methods:

  • Established a cell culture insert-based model using iPSC-derived proximal tubule cells.
  • Maintained the model in a microphysiological system for up to ten days.
  • Utilized perfusion to simulate dynamic physiological conditions and assessed responses to known nephrotoxicants (polymyxin B, cyclosporin A, cisplatin).

Main Results:

  • The perfused iPSC-derived PT model successfully predicted drug-induced proximal tubule injury.
  • Perfusion significantly influenced the model's response to xenobiotics.
  • Upregulation of metallothioneins, a marker of in vivo nephrotoxicity, was detected in the dynamic, perfused model but not in static cultures.
  • The model facilitated the investigation of nephrotoxicity prevention, demonstrating curcumin's potential to alleviate polymyxin-induced injury.

Conclusions:

  • The perfused iPSC-derived proximal tubule model is a versatile and effective tool for in vitro nephrotoxicity studies.
  • This model enables reliable early detection of nephrotoxic potential, supporting safer drug development.
  • Dynamic, perfused in vitro systems are crucial for accurately mimicking in vivo responses to nephrotoxic agents and for evaluating protective strategies.

Related Concept Videos

Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.1K
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
104
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
24
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.1K
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
29
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
36